Latest News

May 2012: Phebra achieves milestone during new plant construction.

December 2011: Phebra Pharmaceuticals Welcomes New Federal Ministers

February 2011: New $16 Million Manufacturing Plant

February 2011: Benztrop^TM (Benztropine mesylate) Tablets - Supply Issues

February 2011: Tadim receives marketing approval in Australia

February 2011: Phebra Injects $16 Million into new manufacturing plant

December 2010: Paraldehyde Injection BP (AUSTR 160612) supply in Australia

December 2010: Proladone (oxycodone) supply resumes

December 2010: Pluscaine ^®- New Anaesthetic Gel 

December 2010: Name Change of Calcium Gluconate Injection

October 2010: Phebra Launches new product (Acetadote^®) for Paracetamol Poisoning

May 2010: Marketing Approval - Cafnea™ (caffeine citrate) Injection and Oral Solution

October 2009: Special Products licenses epilepsy treatment to Phebra

October 2009: Cumberland Pharmaceuticals licenses Caldolor for ANZ

October 2009: Strategic partnership with Conventia Medical

October 2009: Haemorol™ (oily phenol injection) granted marketing approval

September 2009: Paraldehyde Injection has been granted marketing approval

August 2009: Tobra-day ^TM PBS Listing 

August 2009: Marketing Approval - Glaumox ^TM